Table 2.
Clinical and Demographic Characteristics (N = 686)
| Characteristic | No. (%) |
|---|---|
| Age, y (n = 686) | |
| <45 | 224 (32.7) |
| 45–64 | 294 (42.9) |
| ≥65 | 168 (24.5) |
| Sex (n = 686) | |
| Female | 186 (27.1) |
| Male | 500 (72.9) |
| BMI, kg/m2 (n = 685) | |
| <18.5 | 143 (20.9) |
| 18.5–23.9 | 394 (57.5) |
| ≥24 | 148 (21.6) |
| Smear (n = 686) | |
| Negative | 354 (51.6) |
| Positive | 332 (48.4) |
| Cavitary lesions on chest radiograph (n = 686) | |
| No | 441 (64.3) |
| Yes | 245 (35.7) |
| Alcohol use (n = 686) | |
| No | 587 (85.6) |
| Yes | 99 (14.4) |
| Diabetes mellitus (n = 686) | |
| No | 450 (65.6) |
| Yes | 236 (34.4) |
| Cancer (n = 684) | |
| No | 643 (94.0) |
| Yes | 41 (6.0) |
| Chronic kidney disease (n = 680) | |
| No | 634 (93.2) |
| Yes | 46 (6.8) |
| Liver disease (n = 679) | |
| No | 582 (85.7) |
| Yes | 97 (14.3) |
| Hypertension (n = 686) | |
| No | 524 (76.4) |
| Yes | 162 (23.6) |
| Cardiovascular disease (n = 680) | |
| No | 622 (91.5) |
| Yes | 58 (8.5) |
| History of anti-TB treatment (n = 686) | |
| No | 309 (45.0) |
| First-line drugs | 324 (47.2) |
| Second-line drugs | 53 (7.7) |
| Type of case registration (n = 686) | |
| New | 351 (51.2) |
| Retreatment | 335 (48.8) |
| Relapse | 189 (27.6) |
| Treatment after loss to follow-up | 17 (2.5) |
| Treatment after treatment failure | 129 (18.8) |
Abbreviations: BMI, body mass index; TB, tuberculosis.